Current and new antitumor necrosis factor agents in perspective

doi:10.1186/ar994

Review

. 2004;6 Suppl 2(Suppl 2):S1-2.

doi: 10.1186/ar994. Epub 2004 Jun 21.

Current and new antitumor necrosis factor agents in perspective

Ravinder N Maini¹

Affiliations

PMID: 15228614
PMCID: PMC2833459
DOI: 10.1186/ar994

Review

Current and new antitumor necrosis factor agents in perspective

Ravinder N Maini. Arthritis Res Ther. 2004.

. 2004;6 Suppl 2(Suppl 2):S1-2.

doi: 10.1186/ar994. Epub 2004 Jun 21.

Author

Ravinder N Maini¹

Affiliation

¹ Kennedy Institute of Rheumatology, Imperial College of Science, Technology and Medicine, London, UK. r.maini@imperial.ac.uk

PMID: 15228614
PMCID: PMC2833459
DOI: 10.1186/ar994

No abstract available

PubMed Disclaimer

Cited by

HLA-B27 modulates intracellular growth of Salmonella pathogenicity island 2 mutants and production of cytokines in infected monocytic U937 cells.
Ge S, He Q, Granfors K. Ge S, et al. PLoS One. 2012;7(3):e34093. doi: 10.1371/journal.pone.0034093. Epub 2012 Mar 28. PLoS One. 2012. PMID: 22470519 Free PMC article.
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J, Alfredsson L, Begovich AB, Klareskog L, Huizinga TW, Toes RE. Kurreeman FA, et al. PLoS Med. 2007 Sep;4(9):e278. doi: 10.1371/journal.pmed.0040278. PLoS Med. 2007. PMID: 17880261 Free PMC article.
Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27.
Vähämiko S, Penttinen MA, Granfors K. Vähämiko S, et al. Arthritis Res Ther. 2005;7(4):136-41. doi: 10.1186/ar1762. Epub 2005 May 26. Arthritis Res Ther. 2005. PMID: 15987495 Free PMC article. Review.
Tumor necrosis factor receptor-associated factor 1 influences KRN/I-Ag7 mouse arthritis autoantibody production.
Cheng T, Choi Y, Finkel TH, Tsao PY, Ji MQ, Eisenberg RA. Cheng T, et al. J Clin Immunol. 2013 May;33(4):759-66. doi: 10.1007/s10875-013-9866-5. Epub 2013 Jan 26. J Clin Immunol. 2013. PMID: 23354839 Free PMC article.

References

1. Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today. 1997;18:487–492. doi: 10.1016/S0167-5699(97)01118-3. - DOI - PubMed
1. Punzi L, Calo L, Plebani M. Clinical significance of cytokine determination in synovial fluid. Crit Rev Clin Lab Sci. 2002;39:63–88. doi: 10.1080/10408360290795448. - DOI - PubMed
1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. - DOI - PubMed
1. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163–196. doi: 10.1146/annurev.immunol.19.1.163. - DOI - PubMed
1. Brennan FM, Maini RN, Feldmann M. TNF alpha – a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992;31:293–298. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today. 1997;18:487–492. doi: 10.1016/S0167-5699(97)01118-3. - DOI - PubMed

[2] Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today. 1997;18:487–492. doi: 10.1016/S0167-5699(97)01118-3. - DOI - PubMed

[3] Punzi L, Calo L, Plebani M. Clinical significance of cytokine determination in synovial fluid. Crit Rev Clin Lab Sci. 2002;39:63–88. doi: 10.1080/10408360290795448. - DOI - PubMed

[4] Punzi L, Calo L, Plebani M. Clinical significance of cytokine determination in synovial fluid. Crit Rev Clin Lab Sci. 2002;39:63–88. doi: 10.1080/10408360290795448. - DOI - PubMed

[5] Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. - DOI - PubMed

[6] Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. - DOI - PubMed

[7] Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163–196. doi: 10.1146/annurev.immunol.19.1.163. - DOI - PubMed

[8] Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163–196. doi: 10.1146/annurev.immunol.19.1.163. - DOI - PubMed

[9] Brennan FM, Maini RN, Feldmann M. TNF alpha – a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992;31:293–298. - PubMed

[10] Brennan FM, Maini RN, Feldmann M. TNF alpha – a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992;31:293–298. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Current and new antitumor necrosis factor agents in perspective

Affiliation

Current and new antitumor necrosis factor agents in perspective

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources